Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Regulus Therapeutics PE Ratio 2011-2020 | RGLS

For a detailed definition, formula and example for PE Ratio, check out our new background page here.

Current and historical p/e ratio for Regulus Therapeutics (RGLS) from 2011 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Regulus Therapeutics PE ratio as of January 25, 2021 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
Regulus Therapeutics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-01-25 1.28 0.00
2020-09-30 0.51 $-0.75 0.00
2020-06-30 0.68 $-0.97 0.00
2020-03-31 0.46 $-1.04 0.00
2019-12-31 0.89 $-1.10 0.00
2019-09-30 0.72 $-1.85 0.00
2019-06-30 1.25 $-2.77 0.00
2019-03-31 1.02 $-4.03 0.00
2018-12-31 0.93 $-5.52 0.00
2018-09-30 2.37 $-6.22 0.00
2018-06-30 7.91 $-7.20 0.00
2018-03-31 8.61 $-10.56 0.00
2017-12-31 12.48 $-13.33 0.00
2017-09-30 15.00 $-16.21 0.00
2017-06-30 11.83 $-18.49 0.00
2017-03-31 19.80 $-18.37 0.00
2016-12-31 27.00 $-18.61 0.00
2016-09-30 39.60 $-15.73 0.00
2016-06-30 34.68 $-14.29 0.00
2016-03-31 83.16 $-14.41 0.00
2015-12-31 104.64 $-13.09 0.00
2015-09-30 78.54 $-17.05 0.00
2015-06-30 131.52 $-17.17 0.00
2015-03-31 203.28 $-15.73 0.00
2014-12-31 192.48 $-15.85 0.00
2014-09-30 81.96 $-11.52 0.00
2014-06-30 96.48 $-9.24 0.00
2014-03-31 108.24 $-8.16 0.00
2013-12-31 88.68 $-6.96 0.00
2013-09-30 113.16 $-8.28 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.051B $0.007B
Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs, called microRNA therapeutics. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulus Therapeutics Inc. is based in La Jolla, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.625B 42.31
Takeda Pharmaceutical (TAK) Japan $57.159B 10.66
Astellas Pharma (ALPMY) Japan $30.180B 18.85
Merck (MKGAF) Germany $22.343B 0.00
Eisai (ESALY) Japan $21.878B 19.06
UCB SA (UCBJF) Belgium $20.793B 0.00
Catalent (CTLT) United States $19.240B 57.55
Grifols, S.A (GRFS) Spain $13.098B 15.00
Neurocrine Biosciences (NBIX) United States $10.923B 85.96
Jazz Pharmaceuticals (JAZZ) Ireland $9.396B 15.18
Ionis Pharmaceuticals (IONS) United States $8.634B 84.59
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.530B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $8.433B 0.00
United Therapeutics (UTHR) United States $7.453B 15.87
IPSEN SA ADR (IPSEY) France $7.292B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.943B 402.83
Sage Therapeutics (SAGE) United States $4.609B 0.00
ChemoCentryx (CCXI) United States $4.457B 0.00
FibroGen (FGEN) United States $4.328B 0.00
PTC Therapeutics (PTCT) United States $4.323B 0.00
Hypermarcas (HYPMY) Brazil $4.041B 15.95
Cronos Group (CRON) Canada $3.789B 0.00
Corcept Therapeutics (CORT) United States $3.260B 31.53
Nektar Therapeutics (NKTR) United States $2.971B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.951B 15.06
Pacira BioSciences (PCRX) United States $2.948B 64.02
Revolution Medicines (RVMD) United States $2.866B 0.00
Xencor (XNCR) United States $2.787B 0.00
Tilray (TLRY) Canada $2.406B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.881B 0.00
USANA Health Sciences (USNA) United States $1.823B 16.05
Translate Bio (TBIO) United States $1.712B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.655B 14.16
BioCryst Pharmaceuticals (BCRX) United States $1.626B 0.00
Heron Therapeutics (HRTX) United States $1.609B 0.00
Endo (ENDP) Ireland $1.596B 2.42
Ocular Therapeutix (OCUL) United States $1.520B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.490B 10.35
ImmunoGen (IMGN) United States $1.437B 0.00
Trillium Therapeutics (TRIL) Canada $1.328B 0.00
Indivior (INVVY) United States $1.313B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.160B 0.00
Organogenesis Holdings (ORGO) United States $1.139B 0.00
Karyopharm Therapeutics (KPTI) United States $1.111B 0.00
Zogenix (ZGNX) United States $1.074B 0.00
Radius Health (RDUS) United States $1.010B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.960B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Collegium Pharmaceutical (COLL) United States $0.828B 48.84
Calliditas Therapeutics AB (CALT) Sweden $0.789B 0.00
Aerie Pharmaceuticals (AERI) United States $0.787B 0.00
Aclaris Therapeutics (ACRS) United States $0.782B 0.00
VAXART, INC (VXRT) United States $0.782B 0.00
Esperion Therapeutics (ESPR) United States $0.723B 0.00
Acutus Medical (AFIB) United States $0.723B 0.00
Sundial Growers (SNDL) Canada $0.716B 0.00
Ardelyx (ARDX) United States $0.652B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.634B 0.00
Chinook Therapeutics (KDNY) United States $0.634B 0.00
Molecular Templates (MTEM) United States $0.602B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.582B 0.00
Flexion Therapeutics (FLXN) United States $0.569B 0.00
Harpoon Therapeutics (HARP) United States $0.551B 0.00
Siga Technologies (SIGA) United States $0.543B 15.26
PROFOUND MEDICL (PROF) Canada $0.509B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.501B 0.00
Jounce Therapeutics (JNCE) United States $0.500B 0.00
Akebia Therapeutics (AKBA) United States $0.486B 0.00
Altimmune (ALT) United States $0.475B 0.00
Summit Therapeutics (SMMT) United States $0.462B 0.00
DURECT (DRRX) United States $0.457B 0.00
TherapeuticsMD (TXMD) United States $0.450B 0.00
CASI Pharmaceuticals (CASI) United States $0.420B 0.00
Rafael Holdings (RFL) United States $0.412B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.393B 0.00
Jaguar Animal Health (JAGX) United States $0.382B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.373B 9.73
Innate Pharma SA (IPHYF) France $0.371B 0.00
MEI Pharma (MEIP) United States $0.336B 0.00
Concert Pharmaceuticals (CNCE) United States $0.331B 0.00
Nature's Sunshine Products (NATR) United States $0.317B 20.44
Menlo Therapeutics (VYNE) United States $0.316B 0.00
Alpine Immune Sciences (ALPN) United States $0.312B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.311B 0.00
KalVista Pharmaceuticals (KALV) United States $0.289B 0.00
Redhill Biopharma (RDHL) Israel $0.286B 0.00
Lannett Co Inc (LCI) United States $0.281B 7.40
Infinity Pharmaceuticals (INFI) United States $0.263B 0.00
Xeris Pharmaceuticals (XERS) United States $0.262B 0.00
CTI BioPharma (CTIC) United States $0.254B 0.00
IMV INC (IMV) Canada $0.247B 0.00
Otonomy (OTIC) United States $0.238B 0.00
Calithera Biosciences (CALA) United States $0.219B 0.00
Oncternal Therapeutics (ONCT) United States $0.215B 0.00
OptiNose (OPTN) United States $0.214B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.203B 0.00
IsoRay (ISR) United States $0.195B 0.00
Novan (NOVN) United States $0.191B 0.00
Aquestive Therapeutics (AQST) United States $0.191B 0.00
ProPhase Labs (PRPH) United States $0.185B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.177B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.173B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.168B 0.00
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.161B 0.00
Heat Biologics (HTBX) United States $0.157B 0.00
Champions Oncology (CSBR) United States $0.156B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.151B 0.00
Onconova Therapeutics (ONTX) United States $0.147B 0.00
Lipocine (LPCN) United States $0.146B 0.00
MediWound (MDWD) Israel $0.144B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.123B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.122B 0.00
ElectroCore (ECOR) United States $0.121B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.098B 0.00
Iterum Therapeutics (ITRM) Ireland $0.093B 0.00
SCYNEXIS (SCYX) United States $0.089B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Hemispherx BioPharma (AIM) United States $0.085B 0.00
Recro Pharma (REPH) United States $0.084B 0.00
Natural Alternatives (NAII) United States $0.084B 161.83
Biomerica (BMRA) United States $0.082B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.079B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.077B 0.00
AgeX Therapeutics (AGE) United States $0.072B 0.00
KemPharm (KMPH) United States $0.070B 0.00
CV Sciences (CVSI) United States $0.070B 0.00
Vical (BBI) United States $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.066B 0.00
India Globalization Capital (IGC) United States $0.066B 0.00
PolarityTE (PTE) United States $0.063B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 25.39
NovaBay Pharmaceuticals (NBY) United States $0.042B 0.00
Neos Therapeutics (NEOS) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.040B 5.91
Opiant Pharmaceuticals (OPNT) United States $0.040B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.031B 0.00
Midatech Pharma (MTP) United Kingdom $0.031B 0.00
Can-Fite Biopharma (CANF) Israel $0.031B 0.00
Flex Pharma (SLRX) United States $0.030B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
Cyanotech (CYAN) United States $0.021B 34.90
Bellicum Pharmaceuticals (BLCM) United States $0.021B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
SHINECO INC (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00